Therapeutic Asset Ratings

12,939 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Inno-206 Gastric Carcinoma	City of Hope Medical Center	P1	CCC (48)
L-Prolinamide, N-(19-carboxy-1-oxononadecyl)-L-?-glutamyl-L-arginyl-L-?-aspartylglycyl-L-threonyl-L-alanyl-L-threonyl-L-lysyl-L-alanyl-L-threonyl-L-?-glutamyl-L-arginyl-L-leucyl-L-alanyl-5-carboxy-L-norvalyl-L-phenylalanyl-L-leucyl-L-glutaminyl-L-arginyl-L-seryl-L-seryl-L-phenylalanyl-N-methylglycyl-L-alanyl-N-methyl-L-isoleucyl-L-leucyl-L-seryl-L-seryl-L-threonyl-L-?-glutamyl-L-valylglycyl-L-seryl-L-asparaginyl-L-threonyl-4-hydroxy-, (3?8)-lactam, (4R)- Healthy Volunteers	Zealand Pharma	P1	CCC (48)
ly03010 Psychotic Disorder	Luye Pharma Group Ltd.	P1	CCC (48)
ly03010 Schizophrenia	Luye Pharma Group Ltd.	P1	CCC (48)
mg1113 Hemophilia	GC Biopharma Corp	P1	CCC (48)
Romidepsin Solid Tumor	University of Rochester	P1	CCC (48)
SAFIMALTIB B-Cell Chronic Lymphocytic Leukemia	Janssen Research & Development, LLC	P1	CCC (48)
Sargramostim Parkinson Disease	University of Nebraska	P1	CCC (48)
sl-172154 Primary Peritoneal Carcinoma	Shattuck Labs, Inc.	P1	CCC (48)
Sovleplenib Lymphoma	Hutchmed	P1	CCC (48)
TRASTUZUMAB Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P1	CCC (48)
Ucar T-Cell Idiopathic Multidrug-Resistant Nephrotic Syndrome	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (48)
Ucar T-Cell Systemic Sclerosis	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (48)
VEMURAFENIB Breast Carcinoma	OHSU Knight Cancer Institute	P1	CCC (48)
XENON Interstitial Lung Disease	Thunder Bay Regional Health Research Institute	P1	CCC (48)
XENON Pulmonary Hypertension	Thunder Bay Regional Health Research Institute	P1	CCC (48)
Zofran Neoplasm	UNC Lineberger Comprehensive Cancer Center	P1	CCC (48)
123i-att001 Glioblastoma	Theragnostics Ltd	P1	CC (47)
[14C]AZD9833 Breast Carcinoma	AstraZeneca	P1	CC (47)
177Lu-LNC1004 Solid Tumor, Unspecified, Adult	Yantai LNC Biotechnology Singapore PTE. LTD.	P1	CC (47)
[18f]ucb-2897 Multiple System Atrophy	Invicro	P1	CC (47)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Chronic Lymphocytic Lymphoma	National Cancer Institute (NCI)	P1	CC (47)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE COVID-19	Jonathann Kuo, MD	P1	CC (47)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Dysautonomia	Jonathann Kuo, MD	P1	CC (47)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Dysautonomia-Like Disorder	Jonathann Kuo, MD	P1	CC (47)

Showing 201 to 225 of 12,939 assets

PreviousPage 9 of 518Next